WINDMIL THERAPEUTICS

windmil-therapeutics-logo

WindMIL Therapeutics translates novel insights in bone marrow immunology into life-saving cell therapies for cancer patients. The company leveraging its proprietary platform to develop a novel class of cell therapies called MILs (Marrow Infiltrating Lymphocytes) derived from memory T cells found in the bone marrow. WindMIL Therapeutics was established in 2015 and is based in Baltimore, MD.

#SimilarOrganizations #People #Financial #Website #More

WINDMIL THERAPEUTICS

Social Links:

Industry:
Biotechnology Medical Device Therapeutics

Founded:
2015-01-01

Address:
Princeton, New Jersey, United States

Country:
United States

Website Url:
http://www.windmiltx.com

Total Employee:
11+

Status:
Active

Contact:
410-558-1906

Email Addresses:
[email protected]

Total Funding:
42.5 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Font Awesome


Similar Organizations

aimm-therapeutics-logo

AIMM Therapeutics

production of monoclonal antibodies by immortalisation of B cells from elite patients.

axentless-logo

Axentless

Axentless develops software using advanced algorithmic technologies to enable interactive speech therapy practice for stroke victims.

bioxydyn-logo

Bioxydyn

Bioxydyn specializes in the development and application of new diagnostic imaging tools and imaging services.

cadent-therapeutics-logo

Cadent Therapeutics

Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.

decart-therapeutics-logo

DeCART Therapeutics

DeCART Therapeutics Enhances CAR T cells with small molecule targeted protein modulation to provide better outcomes for cancer patients.

dynamic-entropy-technology-logo

Dynamic Entropy Technology

Dynamic Entropy Technology manufactures medical devices with the purpose of improving new technologies in the field of health sciences.

eureka-therapeutics-logo

Eureka Therapeutics

Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.

gilboa-therapeutics-logo

Gilboa Therapeutics

Gilboa Therapeutics is a next-generation cancer immunotherapy company developing novel T cell therapies for solid cancers.

hornet-therapeutics-logo

Hornet Therapeutics

Hornet Therapeutics provides immune cell metabolism & cell therapy for cancer treatment.

hyperstealth-biotechnology-logo

HyperStealth Biotechnology

HyperStealth Biotechnology develops military camouflage technology used in uniforms, vehicles, hunting tools, and stealth activities.

iconeus-logo

Iconeus

Iconeus is introducing functional ultrasound neuro imaging: a breakthrough preclinical imaging modality for brain activity monitoring.

medarex-logo

Medarex

Medarex, Inc. discovers, develops, and commercializes human antibody-based therapeutic products.

medical-device-innovation-consortium-logo

Medical Device Innovation Consortium

MDIC is a public-private partnership created with the sole objective of advancing medical device regulatory science for patient benefit.

my01-logo

MY01

MY01 offers real-time, accurate muscle pressure measurement that allows users to take timely action.

n2-biomedical-llc-logo

N2 Biomedical LLC

N2 Biomedical offers treatments like IBAD, Nano-engineered coatings and ion implantation surface on medical implants devices.

northwest-physicians-laboratories-logo

Northwest Physicians Laboratories

Northwest Physicians Laboratories operates a clinical medical laboratory that conducts tests on clinical specimens.

quantum-ops-logo

Quantum OPS

Quantum OPS an orthopedic tech company, develops products enabling clinicians to immobilize, stabilize, and position patients for surgery.

sandhill-therapeutics-logo

Sandhill Therapeutics

Sandhill Therapeutics is dedicated to transforming cellular immuno-oncology and developing cancer treatments.

saw-dx-logo

Saw DX

SAW Dx is an emerging point of care diagnostic (POC) device design and manufacturing venture focused on exploiting.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics develops therapeutics for treatment of gram-negative infections.

syncopation-life-sciences-logo

Syncopation Life Sciences

Syncopation Life Sciences is advancing a new generation of adoptive cell therapies for cancers.

theracell-logo

TheraCell

Theracell has two patented platform technologies facilitating stereotactic transplantation of neurons and therapeutic cells into the brain

tri-medics-logo

Tri-Medics

Tri-Medics engages in designing, manufacturing, distributing and selling medical instruments.

vessi-medical-logo

Vessi Medical

Vessi Medical brings a new approach to treat Non-Muscle-Invasive Bladder Cancer (NMIBC) utilizing bladder-specific cryotherapy technology.

vinomis-laboratories-logo

Vinomis Laboratories

Vinomis Laboratories manufactures nutraceutical products based on resveratrol, red wine grape extracts, and concentrated polyphenols.


Current Advisors List

not_available_image

Anna French Board Of director @ WindMIL Therapeutics
Board_member

mark-mcdade_image

Mark McDade Board Of director @ WindMIL Therapeutics
Board_member

Current Employees Featured

not_available_image

Ivan Borrello
Ivan Borrello Founder @ WindMIL Therapeutics
Founder

kimberly-noonan_image

Kimberly Noonan
Kimberly Noonan EVP, CSO & Founder @ WindMIL Therapeutics
EVP, CSO & Founder
2016-04-01

brian-halak_image

Brian Halak
Brian Halak President @ WindMIL Therapeutics
President

Founder


not_available_image

Ivan Borrello

kimberly-noonan_image

Kimberly Noonan

Investors List

medivate-partners_image

Medivate Partners

Medivate Partners investment in Series B - WindMIL Therapeutics

camden-partners_image

Camden Partners

Camden Partners investment in Series B - WindMIL Therapeutics

domain-associates_image

Domain Associates

Domain Associates investment in Series B - WindMIL Therapeutics

qiming-venture-partners_image

Qiming Venture Partners

Qiming Venture Partners investment in Series B - WindMIL Therapeutics

foxkiser-llc_image

FoxKiser

FoxKiser investment in Series B - WindMIL Therapeutics

scott-h-cohen_image

Scott H. Cohen

Scott H. Cohen investment in Series A - WindMIL Therapeutics

Official Site Inspections

http://www.windmiltx.com

  • Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
  • IP address: 3.33.130.190
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...

More informations about "WindMIL Therapeutics"

WindMIL Therapeutics - Crunchbase Company Profile & Funding

WindMIL Therapeutics translates novel insights in bone marrow immunology into life-saving cell therapies for cancer patients. The company leveraging its proprietary platform to develop a …See details»

WindMIL Therapeutics - Craft

May 6, 2021 WindMIL Therapeutics is a company focusing on oncology cell therapy. It develops a class of cell therapies called MILs (marrow infiltrating lymphocytes) derived from memory T …See details»

WindMIL Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...

Www.windmiltx.com. Holding Company | 2015 | New Jersey, United States | 10-50 | www.windmiltx.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational …See details»

WindMIL Therapeutics - Overview, News & Similar companies

May 6, 2021 Who is WindMIL Therapeutics. WindMIL Therapeutics is a clinical-stage company developing a novel class of autologous cell therapies based on marrow-infiltrating lymphocytes …See details»

WindMIL Therapeutics - LinkedIn

WindMIL Therapeutics is Evolving We are thankful to the internal team and all the patients, clinicians, and many others who have helped us on our journey thus far in finding better …See details»

WindMIL - Company Profile - Tracxn

Aug 6, 2024 WindMIL - Developer of therapeutics for cancer. Raised a total funding of $2.33M over 1 round from 4 investors. Founded by Brian Halak and Kimberly Noonan in the year …See details»

WindMIL Therapeutics - PitchBook

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations; US-20230100744-A1: Methods for enriching marrow infiltrating lymphocytes ("mils"), compositions containing enriched mils, and methods of using …See details»

WindMIL Therapeutics Inc Overview - Salary.com

Discover essential details about WindMIL Therapeutics Inc, including address, contact, and journey of our company's evolution.See details»

WindMIL Therapeutics, Inc. - VentureRadar

Nora Therapeutics is a privately-held biotechnology company focused on developing therapeutics to address IVF failure and recurrent pregnancy loss, two reproductive conditions...See details»

WindMIL Therapeutics and Cognate BioServices Announce

Mar 10, 2020 Cognate is a dynamic, results-driven, organization focused on providing the broadest range of commercialization services to regenerative medicine, cellular …See details»

WindMIL Therapeutics and Cognate BioServices Announce

For more information, please visit: https://windmiltx.com. About Cognate BioServices, Inc. Cognate is a dynamic, results-driven, organization focused on providing the broadest range of …See details»

WindMIL Therapeutics | CipherBio

Explore WindMIL Therapeutics's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»

Windmil Therapeutics, Inc. in Baltimore, MD - (410) 558-1906

Windmil Therapeutics, Inc. is in the Druggists' Preparations (Pharmaceuticals) business. View competitors, revenue, employees, website and phone number.See details»

www.windmiltx.com

Www.windmiltx.comSee details»

WindMIL Therapeutics Announces Marrow-Infiltrating

Oct 20, 2020 For more information, please visit: https://windmiltx.com. WindMIL Therapeutics Media Contact: Gina Cestari 6 Degrees (917) 797-7904 [email protected] ...See details»

WindMIL Therapeutics, Inc.: Drug pipelines, Patents, Clinical trials ...

May 29, 2023 Explore WindMIL Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, 4 news.See details»

How much do WindMIL Therapeutics Inc employees make?

The average annual salary of WindMIL Therapeutics Inc is estimated to be approximate $98,951 per year. The majority pay is between $87,164 to $111,745 per year. Visit Salary.com to find …See details»

Research programme: genetically modified marrow infiltrating ...

Jul 28, 2022 If your organization has a subscription, there are several access options, even while working remotely: Working within your organization’s network Login with …See details»

WindMIL Therapeutics to Present Data Demonstrating Superior

Dec 9, 2019 BALTIMORE and PHILADELPHIA, Dec. 09, 2019 (GLOBE NEWSWIRE) -- WindMIL Therapeutics, a clinical-stage company developing marrow-infiltrating lymphocytes …See details»

WindMIL Therapeutics, Inc. (WindMIL Therapeutics, Inc.) - 药物管 …

了解WindMIL Therapeutics, Inc. (WindMIL Therapeutics, Inc.)公司的药物管线,治疗领域,技术平台,以及它的3项临床试验, 2篇新闻,疾病领域:肿瘤,血液及淋巴系统疾病,免疫系统疾病, …See details»

linkstock.net © 2022. All rights reserved